MRNS(Delisted)
MarinusยทNASDAQ
--
--(--)
MRNS Profile
Marinus Pharmaceuticals, Inc.
A pharmaceutical company that developing innovative therapeutics to treat seizure disorders
5 Radnor Corporate Center, Suite 500, 100 Matsonford Road, Radnor, PA 19087
--
Marinus Pharmaceuticals, Inc., was incorporated in Delaware on August 14, 2003. The Company is a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies for the treatment of epilepsy disorders, including rare hereditary epilepsy and status epilepticus, which includes the use of ZTALMY (ganaxolone). The company is developing ganaxolone for use in two formulations with different routes of administration: intravenous (IV) and oral. The different formulations are designed to maximize the potential therapeutic applications of ganaxolone in adult and pediatric patient populations, including acute and chronic care.
